Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
During the past century, experimental poets in Japan have been stretching the conventional definition of the genre by creating poems in unexpected places, according to a Cornell researcher.
A new app developed by Cornell computer science researchers helps users record highly accurate time-lapse videos of body parts – a surprisingly difficult task and an unmet need in remote medicine and telehealth applications.
Philanthropic organization Schmidt Sciences has named Carla P. Gomes of Cornell Bowers CIS an AI2050 Senior Fellow for her work on innovative AI approaches to advance scientific discovery, focusing on significant sustainability challenges.
A global analysis by Cornell researchers found that recycling all the human and livestock feces and urine on the planet would contribute substantially to meeting the nutrient supply for all crops worldwide, thereby dramatically reducing the dependency on fossil fuels.
Experts’ more stringent online reviews have the effect of compressing aggregate ratings by penalizing higher-quality products compared to their lower-quality alternatives. To address this problem, a research team developed a method for de-biasing ratings.
Microscopic machines engineered by Cornell researchers can autonomously synchronize their movements, opening new possibilities for the use of microrobots in drug delivery, chemical mixing and environmental remediation, among other applications.
Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
